The mechanism of transglutaminase 2 inhibition with glucosamine: Implications of a possible anti-inflammatory effect through transglutaminase inhibition

Journal of Cancer Research and Clinical Oncology

Volumn 136, Issue 1, 2010, Pages 143-150

  Jeong, Kyung Chae ^a   Ahn, Kyung Ohk ^a   Lee, Byung Il ^a   Lee, Chang Hoon ^a   Kim, Soo Youl ^a  

^a National Cancer Center   (South Korea)

Author keywords

Glucosamine; Glucosamine 6 phosphate; I B ; NF B; Transglutaminase

Indexed keywords

1 AMINO 1 DEOXY BETA DEXTRO GALACTOSE; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; DEXTRO GLUCOSAMINE 6 PHOSPHATE; GALACTOSAMINE; GLUCOSAMINE; GLUCOSAMINE 2 SULFATE; GLUCOSAMINE DERIVATIVE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; N ACETYLGLUCOSAMINE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CANCER CELL; CANCER RESISTANCE; CHEMICAL ANALYSIS; CONFORMATIONAL TRANSITION; DRUG ACTIVITY; DRUG INHIBITION; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG SENSITIVITY; DRUG STRUCTURE; GEL ELECTROPHORESIS; IN VITRO STUDY; KINETICS; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BINDING SITES; BIOCATALYSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSAMINE; GLUCOSE-6-PHOSPHATE; GTP-BINDING PROTEINS; GUANOSINE TRIPHOSPHATE; GUINEA PIGS; HUMANS; I-KAPPA B KINASE; KINETICS; MUTATION; NF-KAPPA B; PROTEIN BINDING; TRANSGLUTAMINASES;

EID: 71449107433     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-009-0645-x     Document Type: Article

References (43)

1. GE Begg L Carrington PH Stokes JM Matthews MA Wouters A Husain L Lorand SE Iismaa RM Graham 2006 Mechanism of allosteric regulation of transglutaminase 2 by GTP Proc Natl Acad Sci USA 103 52 19683 19688 10.1073/pnas.0609283103 10.1073/pnas.0609283103 17179049 (Pubitemid 46037492)
2. GE Begg SR Holman PH Stokes JM Matthews RM Graham SE Iismaa 2006 Mutation of a critical arginine in the GTP-binding site of transglutaminase 2 disinhibits intracellular cross-linking activity J Biol Chem 281 18 12603 12609 10.1074/jbc.M600146200 10.1074/jbc.M600146200 16522628 (Pubitemid 43855349)
3. JG Bekesi RJ Winzler 1970 Inhibitory effects of D-glucosamine on the growth of Walker 256 carcinosarcoma and on protein, RNA, and DNA synthesis Cancer Res 30 12 2905 2912 5494575
4. HB Bosmann 1971 Inhibition of protein, glycoprotein, ribonucleic acid and deoxyribonucleic acid synthesis by D-glucosamine and other sugars in mouse leukemic cells L5178Y and selective inhibition in SV-3T3 compared with 3T3 cells Biochim Biophys Acta 240 1 74 93 4329927
5. HB Bosmann 1972 Antineoplastic drug activity in the mitotic cycle-effects of six agents on macromolecular synthesis in synchronous mammalian leukemic cells Biochem Pharmacol 21 14 1977 1988 10.1016/0006-2952(72)90010-X 10.1016/0006-2952(72)90010-X 4675278
6. A Case RL Stein 2007 Kinetic analysis of the interaction of tissue transglutaminase with a nonpeptidic slow-binding inhibitor Biochemistry 46 4 1106 1115 10.1021/bi061787u 10.1021/bi061787u 17240993 (Pubitemid 46184997)
7. A Case J Ni LA Yeh RL Stein 2005 Development of a mechanism-based assay for tissue transglutaminase-results of a high-throughput screen and discovery of inhibitors Anal Biochem 338 2 237 244 10.1016/j.ab.2004.09.047 10.1016/j.ab.2004.09.047 15745743 (Pubitemid 40312587)
8. JT Chen JB Liang CL Chou MW Chien RC Shyu PI Chou DW Lu 2006 Glucosamine sulfate inhibits TNF-alpha and IFN-gamma-induced production of ICAM-1 in human retinal pigment epithelial cells in vitro Invest Ophthalmol Vis Sci 47 2 664 672 10.1167/iovs.05-1008 10.1167/iovs.05-1008 16431966 (Pubitemid 46768396)
9. K Choi M Siegel JL Piper L Yuan E Cho P Strnad B Omary KM Rich C Khosla 2005 Chemistry and biology of dihydroisoxazole derivatives: selective inhibitors of human transglutaminase 2 Chem Biol 12 4 469 475 10.1016/j.chembiol.2005.02. 007 10.1016/j.chembiol.2005.02.007 15850984 (Pubitemid 40588922)
10. S Datta MA Antonyak RA Cerione 2006 Importance of Ca(2+)-dependent transamidation activity in the protection afforded by tissue transglutaminase against doxorubicin-induced apoptosis Biochemistry 45 44 13163 13174 10.1021/bi0606795 10.1021/bi0606795 17073438 (Pubitemid 44707677)
11. A Di Venere A Rossi F De Matteis N Rosato AF Agro G Mei 2000 Opposite effects of Ca(2+) and GTP binding on tissue transglutaminase tertiary structure J Biol Chem 275 6 3915 3921 10.1074/jbc.275.6.3915 10.1074/jbc.275.6.3915 10660544 (Pubitemid 30094616)
12. G Fare DC Sammons FA Seabourne DL Woodhouse 1967 Lethal action of sugars on ascites tumor cells in vitro Nature 213 5073 308 309 10.1038/213308a0 10.1038/213308a0 6067686
13. A Fjelde E Sorkin JM Rhodes 1956 The effect of glucosamine on human epidermoid carcinoma cells in tissue culture Exp Cell Res 10 1 88 98 10.1016/0014-4827(56)90075-1 10.1016/0014-4827(56)90075-1 13294117
14. JY Fok S Ekmekcioglu K Mehta 2006 Implications of tissue transglutaminase expression in malignant melanoma Mol Cancer Ther 5 6 1493 1503 10.1158/1535-7163.MCT-06-0083 10.1158/1535-7163.MCT-06-0083 16818508 (Pubitemid 44070486)
15. JE Folk SI Chung 1985 Transglutaminases Methods Enzymol 113 358 375 10.1016/S0076-6879(85)13049-1 10.1016/S0076-6879(85)13049-1 2868387
16. SJ Friedman T Kimball CD Trotter PJ Skehan 1977 The inhibition of thymidine kinase in glial tumor cells by an amino sugar, D-glucosamine Cancer Res 37 4 1068 1074 844039
17. SJ Friedman CD Trotter T Kimball PJ Skehan 1977 The inhibition of thymidine metabolism in tumor cells treated with D-glucosamine Cancer Res 37 4 1141 1146 844042 (Pubitemid 8088189)
18. JN Gouze A Bianchi P Becuwe M Dauca P Netter J Magdalou B Terlain K Bordji 2002 Glucosamine modulates IL-1-induced activation of rat chondrocytes at a receptor level, and by inhibiting the NF-kappa B pathway FEBS Lett 510 3 166 170 10.1016/S0014-5793(01)03255-0 10.1016/S0014-5793(01)03255-0 11801247 (Pubitemid 34093818)
19. JA Han SC Park 1999 Reduction of transglutaminase 2 expression is associated with an induction of drug sensitivity in the PC-14 human lung cancer cell line J Cancer Res Clin Oncol 125 2 89 95 10.1007/s004320050247 10.1007/s004320050247 10190315 (Pubitemid 29161460)
20. SY Kim 2006 Transglutaminase 2 in inflammation Front Biosci 11 3026 3035 10.2741/2030 10.2741/2030 16720373 (Pubitemid 43800394)
21. DS Kim SS Park BH Nam IH Kim SY Kim 2006 Reversal of drug resistance in breast cancer cells by transglutaminase 2 inhibition and nuclear factor-kappaB inactivation Cancer Res 66 22 10936 10943 10.1158/0008-5472.CAN-06-1521 10.1158/0008-5472.CAN-06-1521 17108131 (Pubitemid 44876992)
22. DS Kim KS Park KC Jeong BI Lee CH Lee SY Kim 2009 Glucosamine is an effective chemo-sensitizer via transglutaminase 2 inhibition Cancer Lett 273 243 249 10.1016/j.canlet.2008.08.015 18804908
23. TS Lai TF Slaughter KA Peoples JM Hettasch CS Greenberg 1998 Regulation of human tissue transglutaminase function by magnesium-nucleotide complexes. Identification of distinct binding sites for Mg-GTP and Mg-ATP J Biol Chem 273 3 1776 1781 10.1074/jbc.273.3.1776 10.1074/jbc.273.3.1776 9430726 (Pubitemid 28133710)
24. R Largo MA Alvarez-Soria I Diez-Ortego E Calvo O Sanchez-Pernaute J Egido G Herrero-Beaumont 2003 Glucosamine inhibits IL-1beta-induced NFkappaB activation in human osteoarthritic chondrocytes Osteoarthr Cartil 11 4 290 298 10.1016/S1063-4584(03)00028-1 10.1016/S1063-4584(03)00028-1 12681956 (Pubitemid 36410882)
25. J Lee YS Kim DH Choi MS Bang TR Han TH Joh SY Kim 2004 Transglutaminase 2 induces nuclear factor-kappaB activation via a novel pathway in BV-2 microglia J Biol Chem 279 51 53725 53735 10.1074/jbc.M407627200 10.1074/jbc.M407627200 15471861 (Pubitemid 40051881)
26. S Liu RA Cerione J Clardy 2002 Structural basis for the guanine nucleotide-binding activity of tissue transglutaminase and its regulation of transamidation activity Proc Natl Acad Sci USA 99 5 2743 2747 10.1073/pnas.042454899 10.1073/pnas.042454899 11867708 (Pubitemid 34240531)
27. K Mehta J Fok FR Miller D Koul AA Sahin 2004 Prognostic significance of tissue transglutaminase in drug resistant and metastatic breast cancer Clin Cancer Res 10 23 8068 8076 10.1158/1078-0432.CCR-04-1107 10.1158/1078-0432.CCR- 04-1107 15585642 (Pubitemid 39587548)
28. Z Molnar JG Bekesi 1972 Cytotoxic effects of D-glucosamine on the ultrastructures of normal and neoplastic tissues in vivo Cancer Res 32 4 756 765 5014787
29. Z Molnar JG Bekesi 1972 Effects of D-glucosamine, D-mannosamine, and 2-deoxy-D-glucose on the ultrastructure of ascites tumor cells in vitro Cancer Res 32 2 380 389 5058193
30. Y Nakamura H Suzuki M Sakaguchi K Mihara 2004 Targeting and assembly of rat mitochondrial translocase of outer membrane 22 (TOM22) into the TOM complex J Biol Chem 279 20 21223 21232 10.1074/jbc.M314156200 10.1074/jbc.M314156200 14985332 (Pubitemid 38656527)
31. K Noguchi K Ishikawa K Yokoyama T Ohtsuka N Nio E Suzuki 2001 Crystal structure of red sea bream transglutaminase J Biol Chem 276 15 12055 12059 10.1074/jbc.M009862200 10.1074/jbc.M009862200 11080504
32. SS Park JM Kim DS Kim IH Kim SY Kim 2006 Transglutaminase 2 mediates polymer formation of I-kappaBalpha through C-terminal glutamine cluster J Biol Chem 281 46 34965 34972 10.1074/jbc.M604150200 10.1074/jbc.M604150200 16987813 (Pubitemid 46036535)
33. DM Pinkas P Strop AT Brunger C Khosla 2007 Transglutaminase 2 undergoes a large conformational change upon activation PLoS Biol 5 12 e327 10.1371/journal.pbio.0050327 10.1371/journal.pbio.0050327 18092889 (Pubitemid 351159708)
34. JH Quastel A Cantero 1953 Inhibition of tumour growth by D-glucosamine Nature 171 4345 252 254 10.1038/171252a0 10.1038/171252a0 13036842
35. F Rencurel G Waeber B Antoine F Rocchiccioli P Maulard J Girard A Leturque 1996 Requirement of glucose metabolism for regulation of glucose transporter type 2 (GLUT2) gene expression in liver Biochem J 314 Pt 3 903 909 8615787
36. S Roseman 2001 Reflections on glycobiology J Biol Chem 276 45 41527 41542 10.1074/jbc.R100053200 10.1074/jbc.R100053200 11553646 (Pubitemid 37371041)
37. A Rubin GF Springer MJ Hogue 1954 The effect of D-glucosamine hydrochloride and related compounds on tissue cultures of the solid form of mouse sarcoma 37 Cancer Res 14 6 456 458 13172712
38. M Siegel C Khosla 2007 Transglutaminase 2 inhibitors and their therapeutic role in disease states Pharmacol Ther 115 2 232 245 10.1016/j.pharmthera.2007.05.003 10.1016/j.pharmthera.2007.05.003 17582505 (Pubitemid 47042912)
39. PA Smethurst M Griffin 1996 Measurement of tissue transglutaminase activity in a permeabilized cell system: its regulation by Ca2+ and nucleotides Biochem J 313 Pt 3 803 808 8611158
40. M Uldry M Ibberson M Hosokawa B Thorens 2002 GLUT2 is a high affinity glucosamine transporter FEBS Lett 524 1-3 199 203 10.1016/S0014-5793(02)03058-2 10.1016/S0014-5793(02)03058-2 12135767 (Pubitemid 34804860)
41. A Verma H Wang B Manavathi JY Fok AP Mann R Kumar K Mehta 2006 Increased expression of tissue transglutaminase in pancreatic ductal adenocarcinoma and its implications in drug resistance and metastasis Cancer Res 66 21 10525 10533 10.1158/0008-5472.CAN-06-2387 10.1158/0008-5472.CAN-06-2387 17079475 (Pubitemid 44799775)
42. VC Yee LC Pedersen I Le Trong PD Bishop RE Stenkamp DC Teller 1994 Three-dimensional structure of a transglutaminase: human blood coagulation factor XIII Proc Natl Acad Sci USA 91 15 7296 7300 10.1073/pnas.91.15.7296 10.1073/pnas.91.15.7296 7913750 (Pubitemid 24226850)
43. L Yuan M Siegel K Choi C Khosla CR Miller EN Jackson D Piwnica-Worms KM Rich 2007 Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy Oncogene 26 18 2563 2573 10.1038/sj.onc.1210048 10.1038/sj.onc.1210048 17099729 (Pubitemid 46632005)